Literature DB >> 7968018

Intravenous iron-sucrose complex to reduce epoetin demand in dialysis patients.

O Nyvad, H Danielsen, S Madsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7968018     DOI： 10.1016/s0140-6736(94)90797-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Unmet needs about iron deficiency in peritoneal dialysis: a Delphi consensus panel.

Authors:  Sandro Mazzaferro; Silvia D'Alonzo; Massimo Morosetti
Journal:  BMC Nephrol       Date:  2022-10-20       Impact factor: 2.585

Review 2.  Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease.

Authors:  Simon D Roger
Journal:  Clin Kidney J       Date:  2017-11-28

3.  Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial).

Authors:  Katherine A Barraclough; Euan Noble; Diana Leary; Fiona Brown; Carmel M Hawley; Scott B Campbell; Nicole M Isbel; David W Mudge; Carolyn L van Eps; Joanna M Sturtevant; David W Johnson
Journal:  BMC Nephrol       Date:  2009-07-28       Impact factor: 2.388

4.  Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial.

Authors:  Shankar P Nagaraju; Adam Cohn; Ayub Akbari; Janet L Davis; Deborah L Zimmerman
Journal:  BMC Nephrol       Date:  2013-03-20       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.